Huawei Technologies is set to open-source its self-developed programming language, Cangjie, marking the latest step in the company’s pursuit of technological self-sufficiency.

The Company will present four scientific posters highlighting advances of Alzheimer’s clinical program and pharmacokinetic characterization of its lead drug candidate, buntanetap.

Saol Therapeutics, a privately held, clinical-stage pharmaceutical company, today announced the presentation of key findings from the Phase III trial of Sodium Dichloroacetate (DCA) for Pyruvate ...

Saol Therapeutics Announces Poster Presentation at the UMDF Mitochondrial Medicine 2025 Conference PR Newswire ROSWELL, Ga. and DUBLIN and HAMILTON, Bermuda, June 19, 2025 ...

HONG KONG, June 9, 2025 /PRNewswire/ -- Ascletis Pharma Inc. (HKEX: 1672, 'Ascletis') announces that poster presentations on preliminary studies of its oral small molecule GLP-1 Receptor (GLP-1R) ...

SAN FRANCISCO, June 20, 2025 (GLOBE NEWSWIRE) -- Structure Therapeutics Inc. (NASDAQ: GPCR), a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics for ...

GAITHERSBURG, Md., June 13, 2025 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a late clinical-stage biopharmaceutical company developing novel peptide-based therapeutics for liver and ...

Crinetics to Showcase the Next Generation of Endocrinology Innovation at ENDO 2025 with Eight Presentations From its Deep Pipeline ...

Java Development Kit (JDK) 25, a planned long-term support release of standard Java due in September, has reached the initial rampdown or bug-fixing phase with 18 features. The final feature ...

Marea Therapeutics, Inc., a clinical-stage biotechnology company harnessing the latest advances in human genetics to develop first-in-class, next-generation medicines for cardioendocrine diseases ...

Aquestive Therapeutics to present Anaphylm™ (epinephrine) Sublingual Film results at CFAAR Summit, potentially the first oral epinephrine treatment.